References
- Karam C, Scelsa SN. Can vitamin D delay the progression of ALS?. Med Hypotheses. 2011;76:643–5.
- Solomon JA, Gianforcaro A, Hamadeh MJ. Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis. PLoS One. 2011;6:e29354.
- Long K, Nguyen LT. Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signalling mechanisms. Mol Brain. 2013;6:16.
- Gianforcaro A, Hamadeh MJ. Dietary vitamin D3 supplementation at 10x the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS: a pilot study. CNS Neurosci Ther. 2012;18:547–57.
- Gianforcaro A, Solomon JA, Hamadeh MJ. Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females. PLoS One. 2013;8:e30243.
- Karam C, Barrett MJ, Imperato T, MacGowan DJ, Scelsa S. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2013; 20:1550–3.
- Sabatelli M, Luigetti M, Laurenti L, Conte A, Madia F, de Matteis S, et al.Neurologic improvement after peripheral blood stem cell transplantation in POEMS. Neurology. 2009;73:1165.
- Shen, L. Further support for vitamin D supplement in delaying the progression of ALS. Medical Hypotheses. 2011;77:698–9.
- Camu W, Tremblier B, Plassot C, Alphandery S, Salsac C, Pageot N, et al. Vitamin D confers protection to motor neurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging. 2013; Nov 13 (epub ahead of print).
- http://www.vitamindcouncil.org/blog/can-vitamin-d-slow-the-progression-of-als/
- http://www.alsforums.com/forum/general-discussion-about-als-mnd/9472-vitamin-d.html
- DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(Suppl): S1689–96.
- Rosen CJ. Clinical practice: vitamin D insufficiency. N Engl J Med. 2011;364:248–54.
- Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998; 78:1193–231.
- Yang S, Smith C, Prahl JM, Luo X, DeLuca HF. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys. 1993;303:98–106.
- Cantorna MT, Hayes CE, DeLuca HF. 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996;93:7861–4.
- Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21:1151–4.
- Hanley DA, Cranney A, Jones G, Whiting A, Leslie DE, Cole DE, et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ. 2010;182:E610–8.
- Norman AW, Bouillon R, Whiting SJ, Veith R, Lips P. Thirteenth workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2007;103:204–5.
- Alexianu ME, Robbins E, Carswell S, Appel SH. 1,alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motor neuron cells. J Neurosci Res. 1998;51:58–66.
- Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motor neuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1994;36:846–58.
- Appel SH, Beers D, Smith RG, Wilson JE. Altered calcium homeostasis in ALS as a target for therapy. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 4):27–32.
- Halicka HD, Zhao H, Li J, Traganos F, Studzinski GP, Darzynkiewicz Z. Attenuation of constitutive DNA damage signalling by 1,25-dihydroxyvitamin D3. Aging (Albany NY). 2012;4:270–8.
- Cardus A, Panzio S, Encinas M, Dolcet X, Gallego C, Aldea M, et al. 1,25dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis. 2009;204:85–9.
- Chabas JF, Alluin O, Rao G, Garcia S, Lavaut MN, Risso JJ, et al. Vitamin D2 potentiates axonal regeneration. J Neurotrauma. 2008;25:1247–56.
- Grimaldi A, Parker B, Capizzi J, Clarkson P, Pescatello L, White M, et al. 25(OH) vitamin D is associated with greater muscle strength in healthy men and women. Med Sci Sports Exerc. 2013;45:157–62.
- Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. Br Med J. 2009;339:3692.
- Bolland M, Grey A, Gamble G, Reid I. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes & Endocrinology. 24 Jan 2014; early online.
- Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res Bull. 2004;64:25–9.
- Pamphlett R, Fang F. Season and weather patterns at time of birth in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:459–64.
- https://nctu.partners.org/ProACT
- http://www.patientslikeme.com/treatment_evaluations/browse?brand=&condition_id=9&id=322-vitamin-d-side-effects-and-efficacy
- http://www.amazon.com/Nature-Made-Vitamin-1000-Tablets/dp/B000CQPIRC
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.